A pilot, open-label, balanced, randomized, fourperiod, two-sequence, two-treatment cross-over study to study the relative bioavailability of test Ivabradine prolonged release tablets (15 mg) given once a day versus CoralanA film-coated tablets (7.5 mg) twice a day at 12 hours apart under fasting and fed conditions in healthy human male subjects

Trial Profile

A pilot, open-label, balanced, randomized, fourperiod, two-sequence, two-treatment cross-over study to study the relative bioavailability of test Ivabradine prolonged release tablets (15 mg) given once a day versus CoralanA film-coated tablets (7.5 mg) twice a day at 12 hours apart under fasting and fed conditions in healthy human male subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Dec 2017

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Angina pectoris
  • Focus Pharmacokinetics
  • Sponsors Abbott Healthcare
  • Most Recent Events

    • 15 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top